Anti-Aggregative Therapy and Laser Iridectomy

Sheba Medical Center

Overview

Our study investigates the effect of anti-aggregative treatment on success and complications of laser iridectomy. The study includes patients scheduled for laser iridectomy due to narrow angles.Patients will undergo first laser treatment with the anti-aggregative treatment and will scheduled for next lase in the other eye after discontinuing the anti-aggregative treatment. The patients will be followed-up for 3 months.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Conditions

Eyes With Narrow Angle

Interventions

The cessation of anti-aggregative treatment for 10 daysDRUG

Eligibility

Sex: ALLMin age: 20 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients with narrow angle that need laser iridectomy and take anti- aggregative treatment * over 20 years old * patients who can stop their anti-aggregative treatment for 10 days Exclusion Criteria: * under coumadin treatment * post ocular surgeries

Locations (1)

Goldschleger Eye Institute

Tel Litwinsky, Israel

RECRUITING

Central Contacts

Hani Levkovitch-Verbin, MD

CONTACT

Hani.Verbin@ sheba.health.gov.il

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.